Table 2 Clinical and disease-related factors of study participants at the university of Gondar comprehensive specialized hospital, Ethiopia, 2024 (n = 218).

From: Prevalence and associated factors of hyperuricemia in chronic kidney disease: evidence from a single-center hospital-based study in Ethiopia, 2024

Variable

Category

Frequency (%)

Knowledge of optimal serum uric acid (UA) level

Yes

42 (19.3%)

No

176 (80.7%)

Knowledge of hazards of high UA

Yes

38 (17.4%)

No

180 (82.6%)

Drug adherence

Less than 7 days/week

156 (71.6%)

7 days/week

62 (28.4%)

Diet adherence

Adherent

128(58.7%)

Non-adherent

90(41.3%)

Physical activity

Active

128 (58.7%)

Inactive

90 (41.3%)

Smoking status

Current smoker

16 (7.3%)

Ex-smoker (> 1 year)

18 (8.3%)

Non-smoker

184 (84.4%)

Alcohol use

Regular user

5 (2.3%)

Occasional user

27 (12.4%)

Stopped

66 (30.3%)

Non-user

120 (55.0%)

Body mass index (BMI)

Mean ± SD

22.67 ± 2.95

BMI category (kg/m2)

< 18.5

9 (4.1%)

18.5–24.9

105 (48.2%)

25–29.9

71 (32.6%)

≥ 30

33 (15.1%)

Comorbidity

Yes

158 (72.5%)

No

60 (27.5%)

Type of comorbidity

Diabetes mellitus (DM)

8 (5.1%)

Hypertension (HTN)

61 (38.6%)

Stroke

4 (2.5%)

Heart failure

1 (0.6%)

Two or more

77 (48.7%)

Others*

7 (4.4%)

Cause of CKD

DM

51 (23.4%)

HTN

99 (45.4%)

Chronic glomerulonephritis (CGN)

40 (18.3%)

ADPKD

11 (5.0%)

Obstructive causes

2 (0.9%)

Others**

15 (6.9%)

Dialysis started

Yes

29 (13.3%)

No

189 (86.7%)

  1. Others*: HIV, bronchial asthma, hypothyroidism, Others**: HIV-associated (6), solitary kidney (3), renovascular disease (3), urate nephropathy (3), ADPKD – Autosomal Dominant Polycystic Kidney Disease; CGN – Chronic Glomerulonephritis; DM – Diabetes Mellitus; HTN – Hypertension; UA – Uric Acid.